OVDs ideal for microincision surgery

Article

Moderately cohesive ophthalmic viscosurgical devices offer desired performance traits

She presented findings from a study evaluating the OVD behaviour and endothelial cell loss in groups of 20 eyes each operated on using PhysioVisc Integral (PhysIOL, Liège, Belgium), Amvisc Plus (Bausch + Lomb Surgical, Greater London, UK) or Z-Hyalin Plus (Carl Zeiss Meditec, Jena, Germany). All surgeries were performed using the same phacoemulsification platform (Stellaris, Bausch + Lomb) and a bimanual microincision technique involving two 1.2 mm incisions and with enlargement of one incision to 1.7 mm for IOL implantation.

Observations

"When surgeons perform cataract surgery through self-sealing incisions, the OVD is expected to maintain the anterior chamber depth so as to facilitate the capsulorhexis," she explained. "However, while the OVD needs to provide space and tissue protection, if it is not spontaneously expelled during surgical manoeuvers, particularly during hydrodissection, there is a risk of overpressurisation that can lead to capsule rupture.

"The study results show that each of these OVDs offers behaviour that is in line with [the] surgeon's expectations and that the OVDs provided good protection for the corneal endothelium," Dr Deidier added.

As moderately cohesive OVDs, all three products evaluated in the study have high viscosity, strong elasticity and strong pseudoplasticity that allow easy injection through a 27-gauge cannula and removal at the end of the procedure, even with 1.2 mm microincision instruments, noted Dr Deidier.

The three study groups were similar with respect to mean patient age (72 to 76 years), cataract grade (about LOCS III) and preoperative ECC measured by specular microscopy (about 2400 cells/mm2). Based on measurements performed at a month after surgery, mean ECC loss was 1% in eyes operated on with PhysioVisc Integral, 1.09% in the Amvisc Plus group and 1.01% for the Z-Hyalin Plus procedures.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.